Advertisement
Saturday, Dec 03, 2022
Outlook.com
Outlook.com

AstraZeneca May Have Used Outdated Information In Covid-19 Vaccine Trial: US Health Officials

The US officials’ comments come just a day after AstraZeneca had said that its covid-19 jab was 79 percent effective

AstraZeneca May Have Used Outdated Information In Covid-19 Vaccine Trial: US Health Officials
Representational Image | PTI
AstraZeneca May Have Used Outdated Information In Covid-19 Vaccine Trial: US Health Officials
outlookindia.com
2021-03-23T16:52:50+05:30

Results from a US trial of AstraZeneca's Covid-19 vaccine may have included “outdated information” and that could mean the company provided an incomplete view of efficacy data, American federal health officials said early Tuesday.

A spokesman from the drug company said Tuesday it was “looking into it.”

AstraZeneca reported Monday that its Covid-19 vaccine provided strong protection among adults of all ages in a long-anticipated US study, a finding that some experts hoped would help rebuild public confidence in the shot around the world and move it a step closer to clearance in the US.

In the study of more than 30,000 people, the company reported that the vaccine was found to be 79 per cent effective at preventing symptomatic cases of Covid-19 — including in older adults. There were no severe illnesses or hospitalizations among vaccinated volunteers, compared with five such cases in participants who received dummy shots — a small number, but consistent with findings from Britain and other countries that the vaccine protects against the worst of the disease.

AstraZeneca also said the study's independent safety monitors found no serious side effects, including no increased risk of rare blood clots like those identified in Europe, a scare that led numerous countries to briefly suspend vaccinations last week.

But just hours after those encouraging results were reported, the US National Institute of Allergy and Infectious Diseases issued an unusual statement.

The agency said the Data and Safety Monitoring Board “expressed concern that AstraZeneca may have included outdated information from that trial, which may have provided an incomplete view of the efficacy data.”

“We urge the company to work with the DSMB to review the efficacy data and ensure the most accurate, up-to-date efficacy data be made public as quickly as possible,” the statement added.

The company aims to file an application with the Food and Drug Administration in the coming weeks, and the government's outside advisers will then publicly debate the evidence.

Authorization and guidelines for use of the vaccine in the United States will be determined by the FDA and Centers for Disease Control and Prevention after thorough review of the data by independent advisory committees.

Advertisement

Outlook Newsletters

Advertisement
Advertisement
Advertisement

Read More from Outlook

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

Lament Of Separation: Songs Of Habba Khatun, Last Queen Of Kashmir, Still Echo In Valley

In happy times and sad, Habba Khatun’s sensuous songs make both young and old emotional. With the never-ending conflict bringing tragedies to every doorstep, Habba’s lyrics of separation amplify their mourning.

How Indian Laws Govern People’s Right To Love And Live

How Indian Laws Govern People’s Right To Love And Live

In India, only those relationships between a man and a woman are considered to be legitimate when there is a marriage between the two.

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Kohli Quits Test Captaincy, Leaves Leadership Vacuum

Virat Kohli, 33, had recently stepped down as India's T20I captain and was subsequently removed as the ODI captain.

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

UP Elections 2022: How Congress Is Harnessing Power Of 'Persecuted' Women To Counter BJP

A Mahila Congress leader, who is the face of the ‘Ladki Hoon, Lad Sakti Hoon’ campaign, however, has accused the party of anti-women bias after she was denied a ticket.

Advertisement